Podcast Center
Video Center
Webcasts
Resource Center
Events
August 31, 2015 at 08:00 PM
Behind the sizzling performance of health care stocks is sizzling earnings growth.
The health care sector has seen the largest percentage of companies report actual Q2 2015 EPS above estimates (94%) and actual sales above estimates (69%) among the 10 S&P industry sectors, according to FactSet.
Through the Aug. 7 market close, the Sector SPDR Healthcare ETF (XLV) continued its outperformance of the broader U.S. stock market with a 10.84% year-to-date gain compared to just a 2.12% gain for the S&P 500.
XLV holds a basket of 58 health care stocks within the S&P 500 including blue chips like Johnson & Johnson, Amgen, and Pfizer. The fund has $15.87 billion in assets and charges annual expenses of 0.15%.
